WITHUS PHARMACEUTICAL Co., Ltd. (330350) Stock Price & Analysis
330350 Stock Chart & Stats
₩6,370.00₩10.00(0.16%)
At close: 3:30 PM GMT+9
- Day’s Range
- KRW 6,230.00 - KRW 6,510.00
- 52-Week Range
- KRW 5,910.00 - KRW 11,950.00
- Previous Close
- KRW 6,360.00
- Volume
- N/A
- Average Volume (3M)
- 123.87K
- Market Cap
- KRW 84.07B
- Enterprise Value
- KRW 82.96B
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- 10.6
- Beta
- 0.38
- Next Earnings
- Nov 18, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
330350 FAQ
What was WITHUS PHARMACEUTICAL Co., Ltd.’s price range in the past 12 months?
WITHUS PHARMACEUTICAL Co., Ltd. lowest stock price was ₩5910.00 and its highest was ₩11950.00 in the past 12 months.
What is WITHUS PHARMACEUTICAL Co., Ltd.’s market cap?
WITHUS PHARMACEUTICAL Co., Ltd.’s market cap is ₩84.07B.
When is WITHUS PHARMACEUTICAL Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were WITHUS PHARMACEUTICAL Co., Ltd.’s earnings last quarter?
WITHUS PHARMACEUTICAL Co., Ltd. released its earnings results on Aug 14, 2026. The company reported ₩149.115 earnings per share for the quarter.
Is WITHUS PHARMACEUTICAL Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does WITHUS PHARMACEUTICAL Co., Ltd. pay dividends?
WITHUS PHARMACEUTICAL Co., Ltd. does not currently pay dividends.
What is WITHUS PHARMACEUTICAL Co., Ltd.’s EPS estimate?
WITHUS PHARMACEUTICAL Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does WITHUS PHARMACEUTICAL Co., Ltd. have?
WITHUS PHARMACEUTICAL Co., Ltd. has 13,199,680 shares outstanding.
What happened to WITHUS PHARMACEUTICAL Co., Ltd.’s price movement after its last earnings report?
WITHUS PHARMACEUTICAL Co., Ltd. reported an EPS of ₩149.115 in its last earnings report. Following the earnings report the stock price went down -0.132%.
Which hedge fund is a major shareholder of WITHUS PHARMACEUTICAL Co., Ltd.?
Currently, no hedge funds are holding shares in KR:330350
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
WITHUS PHARMACEUTICAL Co., Ltd. (330350) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 1 | 15 |
| Technical Analysis | 6 | 1 | 3 |
| Moving Averages | 0 | 0 | 12 |